Swiss National Bank Has $6.68 Million Position in Oscar Health, Inc. (NYSE:OSCR)

Swiss National Bank raised its holdings in Oscar Health, Inc. (NYSE:OSCR) by 17.8% in the third quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 314,900 shares of the company’s stock after acquiring an additional 47,500 shares during the quarter. Swiss National Bank owned about 0.13% of Oscar Health worth $6,679,000 at the end of the most recent quarter.

Several other hedge funds also recently modified their holdings of the business. Price T Rowe Associates Inc. MD lifted its holdings in Oscar Health by 153.5% in the 1st quarter. Price T Rowe Associates Inc. MD now owns 3,978,152 shares of the company’s stock worth $59,156,000 after purchasing an additional 2,409,160 shares during the last quarter. Renaissance Technologies LLC boosted its holdings in shares of Oscar Health by 31.7% during the 2nd quarter. Renaissance Technologies LLC now owns 3,886,100 shares of the company’s stock worth $61,478,000 after buying an additional 934,600 shares during the period. Point72 Asset Management L.P. acquired a new position in Oscar Health in the 2nd quarter valued at $14,716,000. Bank of New York Mellon Corp raised its holdings in Oscar Health by 161.4% in the 2nd quarter. Bank of New York Mellon Corp now owns 1,393,048 shares of the company’s stock worth $22,038,000 after acquiring an additional 860,226 shares during the period. Finally, Beck Bode LLC acquired a new position in Oscar Health during the 1st quarter worth $9,856,000. Institutional investors and hedge funds own 75.70% of the company’s stock.

Analyst Ratings Changes

OSCR has been the topic of a number of recent analyst reports. Bank of America lowered Oscar Health from a “neutral” rating to an “underperform” rating and dropped their price objective for the stock from $21.00 to $13.50 in a research note on Wednesday, November 6th. UBS Group began coverage on Oscar Health in a report on Monday, October 7th. They set a “neutral” rating and a $23.00 price target for the company. Finally, Piper Sandler restated an “overweight” rating and issued a $28.00 price objective on shares of Oscar Health in a research note on Tuesday, September 10th. One equities research analyst has rated the stock with a sell rating, two have issued a hold rating, four have assigned a buy rating and one has issued a strong buy rating to the company. According to MarketBeat.com, the company has an average rating of “Moderate Buy” and a consensus target price of $22.93.

Insider Activity at Oscar Health

In other news, Director Elbert O. Jr. Robinson sold 25,000 shares of the business’s stock in a transaction on Wednesday, November 20th. The shares were sold at an average price of $17.05, for a total value of $426,250.00. Following the sale, the director now owns 89,512 shares in the company, valued at approximately $1,526,179.60. The trade was a 21.83 % decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. Also, Vice Chairman Joshua Kushner bought 276,040 shares of the company’s stock in a transaction that occurred on Monday, November 11th. The shares were purchased at an average price of $13.58 per share, with a total value of $3,748,623.20. Following the transaction, the insider now directly owns 5,031,262 shares in the company, valued at $68,324,537.96. This represents a 5.80 % increase in their ownership of the stock. The disclosure for this purchase can be found here. Over the last quarter, insiders have acquired 1,055,478 shares of company stock valued at $14,432,852 and have sold 194,569 shares valued at $3,433,319. 25.11% of the stock is currently owned by insiders.

Oscar Health Stock Performance

OSCR opened at $16.28 on Wednesday. The stock’s 50 day simple moving average is $17.68 and its 200-day simple moving average is $18.11. The company has a current ratio of 0.73, a quick ratio of 0.73 and a debt-to-equity ratio of 0.26. The stock has a market cap of $4.03 billion, a PE ratio of -271.29 and a beta of 1.67. Oscar Health, Inc. has a 1 year low of $7.29 and a 1 year high of $23.79.

Oscar Health (NYSE:OSCR) last posted its quarterly earnings results on Thursday, November 7th. The company reported ($0.22) earnings per share for the quarter, missing analysts’ consensus estimates of ($0.20) by ($0.02). Oscar Health had a return on equity of 2.79% and a net margin of 0.35%. The business had revenue of $2.42 billion for the quarter, compared to analyst estimates of $2.33 billion. During the same quarter in the prior year, the firm earned ($0.29) EPS. The firm’s quarterly revenue was up 68.3% on a year-over-year basis. Sell-side analysts forecast that Oscar Health, Inc. will post -0.01 EPS for the current year.

About Oscar Health

Oscar Health, Inc operates as a health insurance in the United States. The company offers health plans in individual and small group markets, as well as +Oscar, a technology driven platform that help providers and payors directly enable their shift to value-based care. It also provides reinsurance products.